Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment.

about

Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways.

P2860

Q54917620-4EFBEF35-7D6C-4ECE-9F11-B467D76F10C2

P2860

Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment.

Item

http://www.wikidata.org/entity/Q47870805

description

2017 nî lūn-bûn

@nan

2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment.

@en

Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment.

@nl

type

Item

label

Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment.

@en

Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment.

@nl

prefLabel

Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment.

@en

Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment.

@nl

P1476

Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment.

@en

P2093

Duo Liu

http://www.w3.org/2001/XMLSchema#string

Nan Wu

http://www.w3.org/2001/XMLSchema#string

Yan Jin

http://www.w3.org/2001/XMLSchema#string

Yuhui Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing

Acute promyelocytic leukemia: where did we start, where are we now, and the future

Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

Advances in understanding cancer genomes through second-generation sequencing

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias

Translocation t(2;11) in CLL cells results in CXCR4/MAML2 fusion oncogene.

Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia.

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

P304

378-384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1389202918666170329110349

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29081694

http://www.w3.org/2001/XMLSchema#string

P932

5635644

http://www.w3.org/2001/XMLSchema#string

Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment.

about

P2860

P2860

Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932